NCT00006242View on ClinicalTrials.gov

BMS-214662 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

September 30, 2005

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

BMS-214662

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006242 - BMS-214662 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter